IRMD
IRadimed CorporationNASDAQHealthcare$96.23-0.32%ClosedMarket Cap: $1.23B
As of 2026-04-06
Valuation
P/E (TTM)
54.72
PEG
3.24
P/B
12.88
P/S
14.59
EV/EBITDA
40.49
DCF Value
$38.00
FCF Yield
1.4%
Div Yield
1.3%
Margins & Returns
Gross Margin
76.7%
Operating Margin
31.2%
Net Margin
26.8%
ROE
23.8%
ROA
20.7%
ROIC
21.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $22.7M | 75.1% | $7.1M | $6.4M | $0.50 | $0.67 |
| FY 2025 | $83.8M | 76.7% | $26.1M | $22.5M | $1.75 | $1.18 |
| Q3 2025 | $21.2M | 77.8% | $6.8M | $5.6M | $0.43 | $0.17 |
| Q2 2025 | $20.4M | 78.2% | $6.8M | $5.8M | $0.45 | $0.17 |
| Q1 2025 | $19.5M | 76.1% | $5.4M | $4.7M | $0.37 | $0.17 |
| Q4 2024 | $19.4M | 76.1% | $5.8M | $5.1M | $0.40 | $0.15 |
| FY 2024 | $73.2M | 76.9% | $22.0M | $19.2M | $1.50 | $0.45 |
| Q3 2024 | $18.3M | 77.4% | $5.8M | $5.0M | $0.40 | $0.15 |
| Q2 2024 | $17.9M | 78.1% | $5.6M | $4.9M | $0.38 | $0.15 |
| Q1 2024 | $17.6M | 76.1% | $4.7M | $4.1M | $0.32 | — |
| Q4 2023 | $17.5M | 76.9% | $5.2M | $4.5M | $0.36 | $0.63 |
| FY 2023 | $65.6M | 76.5% | $20.0M | $17.2M | $1.35 | $1.68 |